COVID-19: Antibody cocktail therapy in Tokyo: Administered at 120 medical institutions
-Governor Koike announced-
Tokyo
Governor Yuriko Koike:
August 12,
At an accommodation facility in Tokyo
For mild and moderate cases of the new coronavirus
The policy to start “antibody cocktail therapy” was clarified.
Antibody cocktail therapy:
Antibody cocktail therapy is limited to hospital use.
The Tokyo Metropolitan Government will meet the conditions of use by having a doctor stationed at the accommodation facility.
It is administered by intravenous drip to patients with new corona to prevent its aggravation.
Administered at 120 medical institutions:
Allow inpatients to be accepted and administered at 120 medical institutions.
At Tokyo Metropolitan Public Hospital
A dedicated bed for antibody cocktail therapy,
She also showed the idea of securing 20 beds.
Nihon Keizai Shimbun
https://www.nikkei.com/article/DGXZQOCC125RQ0S1A810C2000000/
Antibody cocktail therapy may cover more patients
Japan’s health ministry
is working to widen the scope of COVID-19 patients who can receive treatment using two newly approved drugs at the same time.
The ministry says
the treatment will be administered during short-term hospitalization.
In the so-called antibody cocktail treatment,
two drugs are given simultaneously to patients through intravenous drips to suppress the virus’s functions.
A clinical trial carried out overseas confirmed that the therapy reduced the risk of hospitalization or death by 70 percent.
The health ministry
will make arrangements together with local governments so that such patients will be able to receive the antibody cocktail treatment during short-term hospitalization.
The ministry hopes to expand the program as soon as possible.
NHK WORLD-JAPAN News
https://www3.nhk.or.jp/nhkworld/en/news/20210812_03/